VYCOR MEDICAL, INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $418.3K | — | $458.5K | — | — | $513.8K | — |
| Cost of Revenue | — | $73.8K | — | $83.4K | — | — | $61.9K | — |
| Gross Profit | — | $344.4K | — | $375.2K | — | — | $451.9K | — |
| Gross Margin | — | 82.4% | — | 81.8% | — | — | 88.0% | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $322.7K | — | $315.4K | — | — | $405.0K | — |
| Operating Income | — | $6.9K | — | $45.8K | — | — | $32.1K | — |
| Operating Margin | — | 1.6% | — | 10.0% | — | — | 6.2% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-19.1K | — | $20.1K | — | — | $5.0K | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-22.3K | — | $20.1K | — | — | $4.9K | — |
| Net Margin | — | -5.3% | — | 4.4% | — | — | 1.0% | — |
| EPS (Basic) | — | $0.00 | — | $0.00 | — | — | $0.00 | — |
| EPS (Diluted) | — | $0.00 | — | $0.00 | — | — | $0.00 | — |
| Shares Outstanding (Basic) | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M |
| Shares Outstanding (Diluted) | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M | 33.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |